Marijuana MMJ

Medical Marijuana Inc (OTCMKTS:MJNA)’s HempMeds To Market RSHO-X In Colombia

Medical Marijuana Inc (OTCMKTS:MJNA) has announced that its Mexican subsidiary, HempMeds Mexico would be distributing its flagship product, RSHO-X, in Colombia. It should be noted here that the product is currently the only hemp based product, approved for import in Mexico. Moreover, the Colombian government has been re-evaluating its regulations for cannabis-based products, for medical purposes. The company has already showcased the product at the Expo Mede Weed, held in the city of Medellin. The news has helped MJNA record further gains and continue its upward trend in the stock market, as it added another 3.61% to its share value, during the November 28 trading session.

Dr. Stuart Titus, the CEO of MJNA, expressed his excitement at the company being able to reach consumers in Colombia and develop a whole new market. He claimed that not all countries are able to get fast and easy access to CBD products, due to regularity issues. However, once and if the Colombian government approves RSHO-X for import, like Mexico, the Colombians would be able to get easy access to CBD as well.

Dion Markgraff, the president of HempMeds Mexico, expressed pride at being able to attend the expo. He was of the opinion that the event allowed Colombians to interact with different cannabis companies and experts and learn about their products.

Another company working to further develop its marijuana business is Marapharm Ventures Inc (OTCMKTS:MRPHF). The company recently purchased automated cannabis vending machines, through which it aims to boost its presence in marijuana dispensaries and retail stores, where cannabis is legal. MRPHF has announced that the machines would not only reduce the labor costs involved, but would also ensure efficient inventory management and secure storage of its products.

Furthermore, Marapharm plans to introduce these machines in all states, with a cannabis legislation, even where it does not hold a license or have growing operations. In such cases, the machine would hold cannabis products from other companies. The first two machines would be delivered in 2017 and would be installed in Nevada and Washington, under a pilot program.


Terra Tech Corp (OTCMKTS:TRTC) Provides Company and Industry Update

Terra Tech Corp (OTCMKTS:TRTC) has announced that its CEO Derek Peterson was recently interviewed by, in which he provided an industry and company update. The audio interview has been made available on the company website. In his interview, Mr. Peterson discussed the recent election, cabinet appointments and the outlook of the company. He also discussed the state of the cannabis industry and the legalization in Nevada and California.

Separately, the CEO voiced his belief that the incoming government would respect the rights of states to make autonomous decisions, thereby allowing the cannabis industry to thrive. He also pointed out that the president-elect has already claimed that cannabis regulations would be decided on a state-by-state basis, which also indicate that he is aware of the economic benefits the industry has to offer.

Mr. Peterson also stated that a significant amount of tax revenues are being generated, through the industry, since approximately half of the US states have legalized marijuana for medical or recreational use. He also dismissed the beliefs that the new administration might not favor state-level legalization, by claiming that the overwhelming response in favor of marijuana legalization, observed on election day, would make lawmakers reluctant to stifle the new industry.

Terra Tech has also been gaining a lot of attention from analysts of the cannabis industry, which can be seen by the fact that its CEO was recently appointed to the Q&A panel of the Arcview Investor Forum, held in Las Vegas. The event was held on November 15, 2016 and is aimed at helping new and upcoming cannabis companies, network and collaborate with investors. The Arcview Angel Network, which organizes the forum, has over 550 accredited investors and has so far helped over 133 cannabis companies, in raising funds. The event is held on a quarterly basis and is comprised of in-person pitch, which are analyzed by the panel. Mr. Peterson’s inclusion hints that TRTC is being widely viewed as a successful company in the industry.

Terra Tech Corp (OTCMKTS:TRTC) closed at a share price of $0.292, at the end of the November 23 trading session, 10% higher than the day before.


OrganiGram Holdings Inc (OTCMKTS:OGRMF) To Partner With The Trailer Park Boys

OrganiGram Holdings Inc (OTCMKTS:OGRMF) has announced that it has been chosen by the Trailer Park Boys, based in Nova Scotia, as their exclusive Canadian cannabis producer, brand developer and business partner. As per the agreement, the company would be working closely with the management at TPB Productions Ltd, so as to develop a competitive product portfolio, as well as branding and packaging for the users of recreational marijuana. Moreover, Oranigram would serve as the exclusive distributor for the products.

Ray Gracewood, the CCO of OGRMF, stated that the relationship would solidify their strategic building blocks, as they continue to plan for the legalization of recreational cannabis, in Canada. He also revealed that TPB had a vision to develop a national brand and it was exciting to know that OGRMF could assist them. Mr. Gracewood also reaffirmed that OgraniGram would continue to supply world class cannabis, to its patient base. He clarified that the said partnership was aimed at utilizing opportunities that would be available, once recreational cannabis has been legalized.

It should be noted here that TPB was represented by the Sonic Entertainment Group, in this transaction. Louis Thomas, the president of Sonic Entertainment, stated that they were carefully monitoring the situation in Canada, to understand how best they could enter the market. He further claimed that the timing of this partnership and the selection of OrganiGram was decided after meeting with the executive team of OGRMF. The agreement between the two entities would be valid for a period of 5-years.

The announcement comes just a week after OgraniGram announced its financial results for the 3Q2016 and also provided an operational update. In the update, the company stated that it has started construction of its fully funded expansion plans, announced earlier, which are due to be completed by fall 2017. Once complete, the expanded facility would be able to deliver a production capacity of an estimated 17,235 kg of flower per year, which translates to over $100 million in annual sales.

OrganiGram Holdings Inc (OTCMKTS:OGRMF) had a trade volume of 387,421 and gained 26.07%, during the November 23 trading session, to close at $2.47 per share.

Marijuana MMJ

Medical Marijuana Inc (OTCMKTS:MJNA)’s Mexican Arm Featured In Newsweek

Medical Marijuana Inc (OTCMKTS:MJNA) has stated that its Mexican subsidiary, HempMeds has been featured in Newsweek. The company stated that the coverage focused on Real Scientific Hemp Oil-X, a non-psychoactive, THC free hemp based CBD product from HempMeds. It should be noted here that RSHO-X is the first federally approved product in Mexico and was featured in the October 24 version of Newsweek.

In addition to this, the story features the legal status of the cannabis industry in Mexico, the growing market in California and the story of a little girl suffering from epilepsy and how RSHO-X was able to help her. Moreover, the article also features details of MJNA’s growing presence in the Latin American market and how quickly HempMeds is gaining popularity in the country. The CEO of Medical Marijuana, Dr. Stuart Titus, has claimed that the expansion in Latin America is poised to bring substantial economic growth to the company.

Separately, the company announced that HempMeds has opened a new office in Monterey, Mexico, which would be the new headquarters for its Mexican operations. Added to this, the company has also added Carlos Gonzales, as the new COO of HempMeds. Specifically, Mr. Gonzales would focus on improving the sales and distribution of products, from MJNA’s Mexican subsidiary, specially RSHO-X. Dr. Titus commented on the recent developments, stating that the new office provides them with the opportunity to conduct on-ground operations. He further stated that this would help strengthen their relations with the Mexican government, as they continue to educate lawmakers and health officials about the benefits of CBD.

The CEO also welcomed Mr. Gonzales to the management team and expressed confidence in his ability to perform in the Mexican market. It should be noted here that currently RSHO-X has been cleared for the treatment of neuropathic conditions, related to diabetes. Moreover, MJNA believes that its research could possibly lead to the discovery of CBD based treatments for neuro-degenerative and neurological disorders.

Medical Marijuana Inc (OTCMKTS:MJNA) completed the November 23 trading session with a gain of 30.12% in terms of its share value, to reach a close at $0.108 per share.

Business MMJ

Kaya Holdings Inc (OTCMKTS:KAYS) Reports Substantial Growth In Revenues For 3Q2016

Kaya Holdings Inc (OTCMKTS:KAYS) filed its financial results for the 3Q2016, yesterday, recording a gain of 700% in terms of revenue, on a year-over-year basis. The company noted that all of its revenues for the quarter were generated by its cannabis business, rather than other non-cannabis related endeavors. Moreover, the management claimed that it was on track to reach its target of $1 million sales, for the FY2016.

In the accompanying update, the company provided details about the progress of two new Kaya Shack marijuana superstores, being developed by the company. Moreover, Kaya also announced that it has acquired the services of David Kotler, a former prosecutor, with experience in helping companies in their initial phase of medical marijuana licensing. He also has extensive contacts across the marijuana industry, across the nation. Kaya has announced that Mr. Kotler would be responsible for leading the company’s expansion plans, nationwide. Added to this, with the passing of the proposition 64, the company has decided to construct a broad and well rounded executive team, to head out expansion plans in the new and emerging markets.

Kaya Holdings’ CEO, Craig Frank, revealed that the management thought that it was the right time to explore other opportunities, other than their continued expansion in Oregon. He also expressed confidence in the appointment of Mr. Kotler, as the head of national expansion. Commenting on his appointment, Mr. Kotler stated that he believed his job at Kaya was to provide sound guidance on matters relating to licensing and advise connecting where needed.

For its 3Q2016, Kaya recorded revenues of over $263,000 and a gross profit of over $137,000, as compared to a gross loss of $831, in the previous year. However, KAYS also experienced a surge in operating expenses, which increased by approximately three folds, on a year-over-year basis. The majority of this surge was attributable to professional fees. As such, net loss for the 3Q2016 was over $1.12 million, as compared to $1.11 million, in the previous year.

Kaya Holdings Inc (OTCMKTS:KAYS) had a trade volume of 1.09 million and gained 3.7% in terms of its share value, during the November 22 trading session, to reach a close at $0.084 per share.


The Good And The Bad About Canopy Growth Corp (TSE:CGC)

Canopy Growth Corp (CGC) rallying by more than 370% over the last three months is a testament that investors are slowly taking note of opportunities in the cannabis sector. Investors have especially become inquisitive about the Canadian company, given that it boasts a market cap of over $800 million, a feat that is unique in the industry.

 The Good

Interest In the stock has not only been fueled by development in the US on the legalization of Marijuana in eight new states, but the fact that Canada could also legalize the plant. Justin Trudeau government has already given the clearest of indication of its willingness to legalize marijuana for medical purposes. Such a move would essentially lead to the expansion of the target market for Canopy growth, which has already shown what it can do.

Canopy growth is by far the biggest marijuana operator in North America having already accrued a substantial amount of market share in the first growing business. The company’s business model revolves around renting warehouses and using them to grow pot. Its business model places it at the heart of the industry with the expected growth in demand for the plant.

 The Bad

Amidst the impressive run that is unmatched by other stock’s in the industry, the stock faces an uphill task to maintain its recent upward momentum. The entry of professional investors into the industry is one that could spell trouble for the stock as its valuation comes under scrutiny.

A point of concern on the valuation point is the fact that the company generated $18 million in revenue over the last 12 months and still posted a net loss of $8 million. Cash flow of negative $13 million is another red flag for a company that already boasts a valuation of over $800 million.

While the future looks bright for Canopy Growth Corp (CGC) growth, the threat of competition is one that could curtail its impressive run. With the stock trading at highs of $10.48 a share, it awaits to be seen if it will continue powering higher ahead of its 52-week high of $17.86 a share.

Pin It on Pinterest